Malaria drug could combat chemotherapy-resistant head and neck cancers - Medical Xpress
3/14/2022 12:00:00 AM3 years 1 month ago
by Science X staff
by Science X staff
A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumor-killing effects of cisplatin in animal models.
A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumor-killing effects o… [+4687 chars]
full article...